$11.00
+0.92 (+9.13%)
Open$10.12
Previous Close$10.08
Day High$11.13
Day Low$10.07
52W High$17.15
52W Low$10.06
Volume—
Avg Volume273.2K
Market Cap293.58M
P/E Ratio—
EPS$-2.41
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+305.0% upside
Current
$11.00
$11.00
Target
$44.55
$44.55
$33.16
$44.55 avg
$53.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 81.72M | 89.63M | 75.01M |
| Net Income | -102,436,812 | -101,122,223 | -19,564,680 |
| Profit Margin | -125.4% | -119.1% | -26.1% |
| EBITDA | -101,027,609 | -105,271,721 | -21,379,947 |
| Free Cash Flow | — | — | -13,998,479 |
| Rev Growth | -8.8% | -8.8% | -3.9% |
| Debt/Equity | 2.21 | 2.21 | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.16 | +0.29% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.66 | -0.34% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.91 | +0.35% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $550.07 | -0.15% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $911.56 | -0.91% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $151.28 | -3.40% | 7.7 | 20.98B |